As of 2025-07-15, the Gross Margin of Infinity Pharmaceuticals Inc (INFI) is 39.7%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2022-12-31 | 39.7% |
2021-12-31 | 39.7% |
2020-12-31 | 41.2% |
2019-12-31 | -143.3% |
2018-12-31 | 99.5% |
2017-12-31 | - |
2016-12-31 | - |
2015-12-31 | - |
2014-12-31 | - |
2013-12-31 | - |